PEMF Therapy for Enlarged Prostate
Aug 17, 2023
Enlarged prostate – or benign prostatic hyperplasia (BPH) – is a common problem in older males. Based on a highly successful treatment of BPH using pulsed electromagnetic field (PEMF) therapy in dogs, the Parsemus Foundation supported a small clinical trial in men to see if the positive results translated to humans. PEMF therapy for enlarged prostate significantly reduced symptoms and prostate volume, although the reduction was not as extensive as in the canine model. The results of these studies offer hope for a non-invasive, drug-free treatment for enlarged prostate.
The Parsemus Foundation collaborated with medical researchers from Sapienza University in Rome on a small trial using a similar treatment regimen and handheld PEMF device as used in the successful canine study. After one month of treatment (5 mins twice a day) with a Magcell® Microcirc PEMF device, the 27 patients had significantly decreased symptoms and a median decrease of 5.4% of prostate size. Men with moderate-severe lower urinary tract symptoms and without metabolic syndrome (a cluster of conditions that include increased blood pressure, high blood sugar, and excess body fat around the waist) benefited more from the treatment. The study was published in Andrology.
https://www.parsemus.org/humanhealth/treatmen...-prostate/
Aug 17, 2023
Enlarged prostate – or benign prostatic hyperplasia (BPH) – is a common problem in older males. Based on a highly successful treatment of BPH using pulsed electromagnetic field (PEMF) therapy in dogs, the Parsemus Foundation supported a small clinical trial in men to see if the positive results translated to humans. PEMF therapy for enlarged prostate significantly reduced symptoms and prostate volume, although the reduction was not as extensive as in the canine model. The results of these studies offer hope for a non-invasive, drug-free treatment for enlarged prostate.
The Parsemus Foundation collaborated with medical researchers from Sapienza University in Rome on a small trial using a similar treatment regimen and handheld PEMF device as used in the successful canine study. After one month of treatment (5 mins twice a day) with a Magcell® Microcirc PEMF device, the 27 patients had significantly decreased symptoms and a median decrease of 5.4% of prostate size. Men with moderate-severe lower urinary tract symptoms and without metabolic syndrome (a cluster of conditions that include increased blood pressure, high blood sugar, and excess body fat around the waist) benefited more from the treatment. The study was published in Andrology.
https://www.parsemus.org/humanhealth/treatmen...-prostate/
2
